366 related articles for article (PubMed ID: 19383303)
21. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
McGovern JA; Meinert C; de Veer SJ; Hollier BG; Parker TJ; Upton Z
Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
[TBL] [Abstract][Full Text] [Related]
22. Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity.
Tanaka RJ; Ono M; Harrington HA
PLoS One; 2011; 6(5):e19895. PubMed ID: 21647431
[TBL] [Abstract][Full Text] [Related]
23. Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder.
Gong Z; Dai S; Jiang X; Lee M; Zhu X; Wang H; Lin Z
Br J Dermatol; 2023 Jan; 188(1):100-111. PubMed ID: 36689511
[TBL] [Abstract][Full Text] [Related]
24. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.
Clements JA; Willemsen NM; Myers SA; Dong Y
Crit Rev Clin Lab Sci; 2004; 41(3):265-312. PubMed ID: 15307634
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology.
Adamopoulos PG; Kontos CK; Scorilas A
Genomics; 2019 Jul; 111(4):642-652. PubMed ID: 29614347
[TBL] [Abstract][Full Text] [Related]
26. Targeting the kallikrein-related peptidases for drug development.
Sotiropoulou G; Pampalakis G
Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
28. Human tissue kallikreins: physiologic roles and applications in cancer.
Borgoño CA; Michael IP; Diamandis EP
Mol Cancer Res; 2004 May; 2(5):257-80. PubMed ID: 15192120
[TBL] [Abstract][Full Text] [Related]
29. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
Angelopoulou K; Prassas I; Yousef GM
Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
[TBL] [Abstract][Full Text] [Related]
30. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
Swedberg JE; de Veer SJ; Harris JM
Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
[TBL] [Abstract][Full Text] [Related]
31. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
32. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.
Filippou PS; Karagiannis GS; Musrap N; Diamandis EP
Crit Rev Clin Lab Sci; 2016 Aug; 53(4):277-91. PubMed ID: 26886390
[TBL] [Abstract][Full Text] [Related]
33. Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Paliouras M; Diamandis EP
Tumour Biol; 2008; 29(2):63-75. PubMed ID: 18515984
[TBL] [Abstract][Full Text] [Related]
34. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
[TBL] [Abstract][Full Text] [Related]
35. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Emami N; Diamandis EP
Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system.
Bernett MJ; Blaber SI; Scarisbrick IA; Dhanarajan P; Thompson SM; Blaber M
J Biol Chem; 2002 Jul; 277(27):24562-70. PubMed ID: 11983703
[TBL] [Abstract][Full Text] [Related]
37. The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.
Kryza T; Silva ML; Loessner D; Heuzé-Vourc'h N; Clements JA
Biochimie; 2016 Mar; 122():283-99. PubMed ID: 26343558
[TBL] [Abstract][Full Text] [Related]
38. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).
Yousef GM; Diamandis EP
Genomics; 2000 Apr; 65(2):184-94. PubMed ID: 10783266
[TBL] [Abstract][Full Text] [Related]
39. Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semen.
Emami N; Diamandis EP
Biol Chem; 2010 Jan; 391(1):85-95. PubMed ID: 19919178
[TBL] [Abstract][Full Text] [Related]
40. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).
Bayani J; Diamandis EP
Clin Chem Lab Med; 2011 Nov; 50(2):211-33. PubMed ID: 22047144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
